Noxxon Pharma AG (Noxxon)

Oncology Corporate Profile

HQ Location

Max-Dohrn-Strasse 8-10
10589 Berlin, Germany

Company Description

NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Spiegelmers are chemically synthesized L-stereoisomer oligonucleotide aptamers, a non-immunogenic alternative to antibodies. NOXXON has a diversified portfolio of clinical-stage Spiegelmer® therapeutics:

Website: http://www.noxxon.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NOX-A12anti-CXCL12Chronic Lymphocytic Leukemia (CLL)II
NOX-A12anti-CXCL12Multiple MyelomaII
NOX-A12anti-CXCL12Glioblastoma Multiforme (GBM)I

View additional information on product candidates here »

Pipeline image

Source


http://www.noxxon.com

Recent News Headlines

There are no news items to display